Walgreens Boots Alliance
About: Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
Employees: 312,000
0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 6 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
0% more funds holding in top 10
Funds holding in top 10: 4 [Q2] → 4 (+0) [Q3]
2.6% less ownership
Funds ownership: 62.05% [Q2] → 59.45% (-2.6%) [Q3]
6% less funds holding
Funds holding: 917 [Q2] → 862 (-55) [Q3]
11% less call options, than puts
Call options by funds: $246M | Put options by funds: $274M
18% less repeat investments, than reductions
Existing positions increased: 276 | Existing positions reduced: 338
25% less first-time investments, than exits
New positions opened: 114 | Existing positions closed: 153
29% less capital invested
Capital invested by funds: $6.48B [Q2] → $4.62B (-$1.86B) [Q3]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$8.50
32%
downside
Avg. target
$11.42
9%
downside
High target
$14
12%
upside
6 analyst ratings
1 positive
17%
4 neutral
67%
1 negative
17%
Truist Securities David Macdonald 59% 1-year accuracy 57 / 96 met price target | 4%upside $13 | Hold Maintained | 16 Jan 2025 |
RBC Capital Ben Hendrix 29% 1-year accuracy 20 / 70 met price target | 4%downside $12 | Sector Perform Maintained | 15 Jan 2025 |
Evercore ISI Group Elizabeth Anderson 33% 1-year accuracy 11 / 33 met price target | 4%downside $12 | In-Line Maintained | 13 Jan 2025 |
B of A Securities Allen Lutz 69% 1-year accuracy 9 / 13 met price target | 32%downside $8.50 | Underperform Maintained | 13 Jan 2025 |
Jefferies Brian Tanquilut 50% 1-year accuracy 7 / 14 met price target | 28%downside $9 | Hold Maintained | 23 Oct 2024 |
Financial journalist opinion
Based on 76 articles about WBA published over the past 30 days
Neutral
Accesswire
11 hours ago
Bronstein, Gewirtz & Grossman, LLC Encourages Walgreens Boots Alliance, Inc. (WBA) Investors to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walgreens Boots Alliance, Inc. ("Walgreens" or "the Company") (NASDAQ:WBA). Investors who purchased Walgreens securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/WBA.
Neutral
Accesswire
14 hours ago
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Walgreens Boots Alliance, Inc. Investors to Inquire About Securities Class Action Investigation - WBA
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation on behalf of shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) resulting from allegations that Walgreens may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Walgreens securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Negative
Proactive Investors
16 hours ago
Walgreens set for hammering after unlawful opioid allegations
Walgreens Boots Alliance Inc is set for a hammering when the market reopens on Tuesday after being accused by the government of filling unlawful opioid prescriptions. America's US Justice Department late last week alleged the pharmacy chain had contributed to the opioid epidemic by filling millions of unlawful prescriptions.
Neutral
GlobeNewsWire
1 day ago
Walgreens Announcement: If You Have Suffered Losses in Walgreens Boots Alliance, Inc. (NASDAQ: WBA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Jan. 19, 2025 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation on behalf of shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) resulting from allegations that Walgreens may have issued materially misleading business information to the investing public.
Neutral
Accesswire
2 days ago
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Walgreens Boots Alliance, Inc. Investors to Inquire About Securities Class Action Investigation - WBA
NEW YORK, NY / ACCESS Newswire / January 18, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation on behalf of shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) resulting from allegations that Walgreens may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Walgreens securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Negative
Forbes
2 days ago
Justice Department Sues Walgreens Over Unlawful Opioid Prescriptions
The Justice Department has filed a civil complaint against Walgreens which operates more than 8,000 pharmacies throughout the United States alleging that they dispensed millions of illegal prescriptions in violation of the Controlled Substances Act (CSA).
Neutral
Accesswire
2 days ago
Walgreens Stock Drops on News of DOJ Lawsuit Alleging Pharmacy Filled Millions of Prescriptions Without Legitimate Medical Purpose - Kehoe Law Firm, P.C. Investigating - WBA
PHILADELPHIA, PA / ACCESS Newswire / January 18, 2025 / Kehoe Law Firm, P.C. is investigating securities class action claims on behalf of shareholders of Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ:WBA).
Neutral
The Motley Fool
2 days ago
These Were the 5 Worst-Performing Stocks in the S&P 500 in 2024
Returning 25% in 2024, the S&P 500 delivered a record-breaking year for stock market investors. A resilient global economy coupled with interest rate cuts by the Federal Reserve continues to fuel optimism toward a strong outlook.
Positive
Seeking Alpha
2 days ago
7 Stocks I'm Buying Amid This Goldilocks (For Now) Economy
There is an often overlooked difference between income investing and dividend growth investing. The two are not the same. Timely charts showing that inflation is even more subdued than the official CPI metrics show, but also what threatens to disrupt the disinflationary trend. A discussion of three books dividend growth investors would benefit from reading. Only one is specifically about dividend growth investing.
Neutral
Business Wire
3 days ago
Rosen Law Firm Encourages Walgreens Boots Alliance, Inc. Investors to Inquire About Securities Class Action Investigation – WBA
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) resulting from allegations that Walgreens may have issued materially misleading business information to the investing public. So What: If you purchased Walgreens securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fe.
Charts implemented using Lightweight Charts™